Notably, C9+ ALS patients had significantly higher pNFH levels than C9– ALS patients, which presumably reflected increased neurodegeneration, consistent with reports that patients with C9+ ALS develop greater brain atrophy, particularly in extra-motor regions, compared to C9– ALS patients (11–13). Here, C9 is linked to amyotrophic lateral sclerosis.